The DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Open accessAbstract
The blood–brain barrier is playing a critical role in controlling the influx and efflux of biological substances essential for the brain’s metabolic activity as well as neuronal function. Thus, the functional and structural integrity of the BBB is pivotal to maintain the homeostasis of the brain microenvironment. The different cells and structures contributing to developing this barrier are summarized along with the different functions that BBB plays at the brain–blood interface. We also explained the role of shear stress in maintaining BBB integrity. Furthermore, we elaborated on the clinical aspects that correlate between BBB disruption and different neurological and pathological conditions. Finally, we discussed several biomarkers that can help to assess the BBB permeability and integrity in-vitro or in-vivo and briefly explain their advantages and disadvantages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These barriers include the blood–cerebrospinal fluid (blood–CSF) barrier, the blood–retinal barrier, the blood–spinal cord barrier, and the BBB. Among these, the latter is the most extensive and exclusive [5].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the adsorptive-mediated transcytosis (AMT), positively charged molecules interact with the negatively charged ECs, inducing transcytosis and their passage across the barrier.”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The BBB is a physical barrier that separates the CNS from the circulating blood and possesses unique properties for the CNS microvasculature [103].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [103]
The cited source says what the claim attributes to it.
In the citing paper
“Carrier-mediated transport (CMT) refers to the transport of a variety of molecules facilitated by membrane-bound proteins entitled solute carrier (SLC) transporters [5].”
The cited source says what the claim attributes to it.
In the citing paper
“On the other side, in the receptor-mediated transcytosis (RMT), specific molecules bind to their respective receptors present on the surface of these cells, triggering transcytosis, and their release to the brain environment by detaching from the receptor [5].”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589 · cited 1×
“Furthermore, pericytes may display phagocyting functions helping with the removal of toxic metabolites [37].”
BackgroundRetracted(1982) · Trends in Neurosciences · doi:10.1016/0166-2236(82)90076-5 · Cited by 9,089
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595 · cited 6×
“As mentioned early, soluble factors released by many of the cell types associated with brain microvessels (including microglia and astrocytes) as well as nerve terminals adjacent to the endothelial extracellular matrix/basal lamina (such as vasoactive agents and cytokines) can modify tight junction assembly and barrie…”
BackgroundInfluentialAstrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“These latter include (1) compartmentalization of the neural parenchyma; (2) maintenance of the ionic homeostasis of the extracellular space; (3) pH regulation; (4) neurotransmitter uptake and processing by providing energy-rich substrates to the neurons; (5) mediation of signals from neurons to the vasculature [51].”
BackgroundStructure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · cited 11×
“During embryonic angiogenesis, the differentiation of the endothelium into a functioning barrier layer begins and is maintained during adulthood by a close inductive association with other cell types within the NVU, as we mentioned early [2].”
BackgroundInfluentialHenry, M. A. (1995) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1995.0108 · Cited by 3,416
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 1×
“However, specific neuroactive peptides [135], regulatory proteins, hormones, and growth factors get the use of RMT systems to cross the BBB [136].”
BackgroundGhose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999) · Journal of Combinatorial Chemistry · doi:10.1021/cc9800071 · Cited by 3,068 · cited 1×
“There are > 7000 drugs in the Comprehensive Medicinal Chemistry (CMC) database, and only 5% of these drugs treat the CNS [125].”
BackgroundNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · cited 8×
“Abbreviations BBB: Blood–brain barrier; CNS: Central nervous system; CSF: Cerebrospinal fluid; BCB: Blood–CSF barrier; ISF: Interstitial fluid; TJs: Tight junctions; P-gp: P-glycoprotein; BCRP: Breast cancer resistance protein; OATP: Organic anion transporting polypeptide; CYP 450: Cytochrome P450; BM: Basement membra…”
BackgroundInfluential
Research works printed but not linked: 1
- Benagiano V, Virgintino D, Maiorano E, Rizzi A, Palombo S, Roncali L, et al. VIP-like immunoreactivity within neurons and perivascular neuronal processes of the human cerebral cortex. Eur J Histochem. 1996;40(1):53–6.
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115938 · Cited by 1,085
“Because the therapeutic agents need to reach the central nervous system (CNS), it is necessary to tailor appropriate vectors that can surpass the brain–blood barrier (BBB) [3,6].”
BackgroundApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids
Fock, E., & Parnova, R. (2023) · Cells · doi:10.3390/cells12040657 · Cited by 385
Metadata
- Authors
- Kadry, H., Noorani, B., & Cucullo, L.
- Affiliations
- Texas Tech University Health Sciences Center (US)
- Oakland University (US)
- Corresponding author
- Cucullo, Luca
- Venue
- Fluids and Barriers of the CNS
- Published
- 2020-11-18
- Volume
- 17
- Issue
- 1
- Pages
- 69-69
- ISSN
- 2045-8118 (ISSN-L)
- PMC
- PMC7672931
- OpenAlex
- W3104682194
- Cited by
- 1,853
- References
- 266
- Citations by year
- 2026: 342 · 2025: 491 · 2024: 480 · 2023: 299 · 2022: 176 · 2021: 63
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Fluids and Barriers of the CNS (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute on Drug Abuse (2R01-DA029121-01A1, 1R01DA049737-01)
- National Institute of Neurological Disorders and Stroke (1R01NS117906-01)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- blood-brain barrier, blood-brain barrier integrity, blood-brain barrier disruption, shear stress, blood-brain barrier permeability, brain homeostasis, neurological disorders
- MeSH terms
- Biological Transport, Blood-Brain Barrier, Brain Diseases, Humans, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. https://app.cochat.ai/papers/10.1186/s12987-020-00230-3
- The paper
- Kadry, H., Noorani, B., & Cucullo, L. (2020). A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids and Barriers of the CNS. https://doi.org/10.1186/s12987-020-00230-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.